BRISTOL MYERS SQUIBB CO Quarterly Deferred Tax Assets, Valuation Allowance in USD from Q4 2010 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
Bristol Myers Squibb Co quarterly Deferred Tax Assets, Valuation Allowance history and growth rate from Q4 2010 to Q4 2023.
  • Bristol Myers Squibb Co Deferred Tax Assets, Valuation Allowance for the quarter ending December 31, 2023 was $764M, a 12.5% decline year-over-year.
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 $764M -$109M -12.5% Dec 31, 2023 10-K 2024-02-13
Q4 2022 $873M -$183M -17.3% Dec 31, 2022 10-K 2024-02-13
Q4 2021 $1.06B -$1.75B -62.4% Dec 31, 2021 10-K 2023-02-14
Q4 2020 $2.81B -$35M -1.23% Dec 31, 2020 10-K 2022-02-09
Q4 2019 $2.84B -$349M -10.9% Dec 31, 2019 10-K 2021-02-10
Q4 2018 $3.19B +$366M +12.9% Dec 31, 2018 10-K 2020-02-24
Q4 2017 $2.83B -$251M -8.16% Dec 31, 2017 10-K 2019-02-25
Q4 2016 $3.08B -$456M -12.9% Dec 31, 2016 10-K 2018-02-13
Q4 2015 $3.53B -$725M -17% Dec 31, 2015 10-K 2017-02-21
Q4 2014 $4.26B -$364M -7.87% Dec 31, 2014 10-K 2016-02-12
Q4 2013 $4.62B +$219M +4.97% Dec 31, 2013 10-K 2015-02-13
Q4 2012 $4.4B +$484M +12.3% Dec 31, 2012 10-K 2014-02-14
Q4 2011 $3.92B +$2.06B +110% Dec 31, 2011 10-K 2013-02-15
Q4 2010 $1.86B Dec 31, 2010 10-K 2012-02-17
* An asterisk sign (*) next to the value indicates that the value is likely invalid.